That's important as I still think Fuji likely TO 2019.They just assume the "license" deal.
I looked up CYP VWAP Friday (122.5) and also got 5 companies in comparative sector suggested
CSL, MSB, VLA, SRX and CUV,
2 of those were taken out with massive premiums 2018 (SRX and VLA), CSL, well, yeah, out of our league right now, but CUV has done 141% 2018 and outperformed Cynata at 101%.....who said Biotechs don't hold their gains!
I can only think of MSB which has been a 10 year dog from $10 to $1...the worst of the bunch.
Run a 5 year chart over all those comparative companies vs MSB and makes you wonder why they have such a stanch supporters club.
Going forward..., page-420
-
- There are more pages in this discussion • 1,711 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.005(2.00%) |
Mkt cap ! $45.80M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 25.5¢ | 25.5¢ | $313 | 1.229K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22209 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 36715 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |